Article: A randomized Phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.(Report)

Article: J Clin Oncol: High prevalence of vitamin D ...
Alternative Medicine Review;  June 1, 2009 ;     700+ words ...PURPOSE: Vitamin D deficiency is associated with increased breast cancer risk and decreased breast cancer survival. The purpose of this study was to determine the prevalence of vitamin D deficiency, as measured by serum 25-hydroxyvitamin D (25-OHD), in premenopausal women at initiation of adjuvant

Article: Jpn J Clin Oncol. Tobacco smoking and breast cancer ...
Journal of Continuing Education Topics & Issues;  January 1, 2007 ;     649 words ...A MEDLINE search was conducted to identify epidemiological studies on the association between smoking and breast cancer incidence or mortality among the Japanese from 1966 to 2005. Three cohort studies and eight case-control studies were identified. A significantly increased risk among current

Article: Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) ...
Advances in Gastrointestinal Cancer;  September 1, 2008 ;     700+ words ... ... line treatment for metastatic colorectal cancer: a Phase ... younger patients with metastatic colorectal cancer: combined ... Saltz L et al. J Clin Oncol, 2008, 26, 1443 ... line treatment for metastatic colorectal cancer, with median ...

Article: Cetuximab in metastatic colorectal ca.(CLINICAL ...
Internal Medicine News;  April 15, 2005 ;     605 words ... ... the same response rate in metastatic colorectal tumors that test negative ... negative patients with metastatic colorectal cancer was conducted by Ki ... Philadelphia, in an editorial (J. Clin. Oncol. 2005;23:1791-3 ...

Article: YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN ...
PR Newswire;  August 4, 2008 ;     700+ words ... ... nimotuzumab in patients with irinotecan-refractory, metastatic colorectal cancer (mCRC). The data are based on 58 evaluable patients ... irinotecan failure in a similar patient population (J Clin Oncol 26: 2008 May 20 suppl; abstract 4062). That abstract ...

Article: Oral Angiogenesis Inhibitor Enters Phase III Trials for Treatment ...
PR Newswire;  April 2, 2003 ;     700+ words ... ... entered Phase III clinical trials in metastatic colorectal cancer. The trials will evaluate ... chemotherapy for patients with metastatic colorectal cancer. PTK787/ZK 222584 is ... previously untreated patients with metastatic colorectal cancer. The CONFIRM 2 (Colorectal ...

Article: Improved Treatment for Metastatic Colorectal ...
Clinical Oncology Alert;  November 1, 2000 ;     700+ words ... ... Improved Treatment for Metastatic Colorectal Cancer ABSTRACT & ... involving 683 patients with metastatic colorectal cancer was performed to ... 2000;343:905-914. Metastatic colorectal cancer remains an important ...